VERA in the 13F filings
Vera Therapeutics Inc · CUSIP 92337R101
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 4 listed it in both
- Shares listed
- 11,005,373
- combined, among listed positions
- Reported value
- $468m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 8 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -2,642,527.
Managers listing VERA in Q2 2026
22 of 22 holders
Largest increases and reductions, by shares
Increases
- AllianceBernstein LPexisting position · 1,591,043 shares now+276,801
- Fidelity (FMR LLC)existing position · 2,774,070 shares now+97,648
- Squarepoint Ops LLCexisting position · 104,937 shares now+89,253
- D. E. Shaw & Co.existing position · 74,509 shares now+69,009
- Susquehanna International Group LLPexisting position · 160,837 shares now+39,817
Reductions
- Point72 Asset Management LPexisting position · 40,563 shares now-1,170,162
- T. Rowe Price Associates Incexisting position · 4,012,936 shares now-561,094
- ExodusPoint Capital Management LPexisting position · 11,191 shares now-306,160
- Renaissance Technologies LLCexisting position · 279,528 shares now-177,772
- Two Sigma Investments LPexisting position · 104,170 shares now-105,981
New positions and exits
New (2)
Exited (6)
- Citadel Advisors LLCwas $17m
- Hudson Bay Capital Management LPwas $7.7m
- Freestone Grove Partners LPwas $5.9m
- Walleye Capital LLCwas $932k
- Jane Street Group LLCwas $851k
- Quantbot Technologies LPwas $53k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2022 | 1 | $3.6m | n.a. | n.a. |
| Q4 2022 | 3 | $7.8m | n.a. | n.a. |
| Q1 2023 | 1 | $14m | n.a. | n.a. |
| Q2 2023 | 2 | $28m | n.a. | n.a. |
| Q3 2023 | 1 | $35m | n.a. | n.a. |
| Q4 2023 | 1 | $39m | 0 | 1 |
| Q1 2024 | 6 | $185m | 5 | 1 |
| Q2 2024 | 5 | $257m | 4 | 1 |
| Q3 2024 | 6 | $346m | 5 | 1 |
| Q4 2024 | 4 | $351m | 3 | 1 |
| Q1 2025 | 2 | $77m | 1 | 1 |
| Q2 2025 | 2 | $68m | 2 | 0 |
| Q3 2025 | 3 | $71m | 2 | 1 |
| Q4 2025 | 4 | $481m | 17 | 9 |
| Q1 2026 | 6 | $299m | 18 | 10 |
| Q2 2026 | 1 | $43m | 8 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VERA and LLY →VERA and JNJ →VERA and VRTX →Choose a stock to compare with VERA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VERA, latest filings →Back to the 13F Explorer →